BeStock  
Stocks › Biotechnology › GHRS

GH Research GHRS

US equityMarket cap rank #3039Biotechnology
$17.53 −$1.03 (-5.55%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $17.53 0.00%
Open$18.32
Prev close$18.56
Day range$17.29 – $18.32
Volume299.5K
Market cap$1.20B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-19.3x
CheapRich

Around its usual level · 53rd percentile, 5-year average -34.8x

Price / book3.6x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 2.9x

#4018 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-337x-214x-90x34xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$23.50
Price vs. fair value-25.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.65 – 2.93 83% (pricier than usual) #4018 of 5331 (1 = cheapest)
PE -19.29 -13.44 -34.81 53% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on GHRS.

Sign in to join the discussion.

Scroll to Top